Items related to CARDIOMETABOLIC INDICATORS AS PREDICTORS OF EARLY VASCULAR...

CARDIOMETABOLIC INDICATORS AS PREDICTORS OF EARLY VASCULAR AGING: In Patients With Non-alcoholic Fatty Liver Disease And Subclinical Hypothyroidism - Softcover

 
9786202528726: CARDIOMETABOLIC INDICATORS AS PREDICTORS OF EARLY VASCULAR AGING: In Patients With Non-alcoholic Fatty Liver Disease And Subclinical Hypothyroidism

Synopsis

In recent years, the concept of “cardiometabolic risk” is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of “new” markers - C-reactive protein, tumor necrosis factor-α, endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient.

"synopsis" may belong to another edition of this title.

Search results for CARDIOMETABOLIC INDICATORS AS PREDICTORS OF EARLY VASCULAR...

Seller Image

Olena Kolesnikova
ISBN 10: 6202528729 ISBN 13: 9786202528726
New Taschenbuch
Print on Demand

Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In recent years, the concept of 'cardiometabolic risk' is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of 'new' markers - C-reactive protein, tumor necrosis factor- , endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient. 80 pp. Englisch. Seller Inventory # 9786202528726

Contact seller

Buy New

US$ 32.52
Convert currency
Shipping: US$ 26.99
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 2 available

Add to basket

Seller Image

Olena Kolesnikova
Published by LAP LAMBERT Academic Publishing, 2020
ISBN 10: 6202528729 ISBN 13: 9786202528726
New Softcover

Seller: moluna, Greven, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # 385946548

Contact seller

Buy New

US$ 29.69
Convert currency
Shipping: US$ 57.49
From Germany to U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Seller Image

Olena Kolesnikova
ISBN 10: 6202528729 ISBN 13: 9786202528726
New Taschenbuch

Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. Neuware -In recent years, the concept of ¿cardiometabolic risk¿ is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of ¿new¿ markers - C-reactive protein, tumor necrosis factor-¿, endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient.Books on Demand GmbH, Überseering 33, 22297 Hamburg 80 pp. Englisch. Seller Inventory # 9786202528726

Contact seller

Buy New

US$ 32.52
Convert currency
Shipping: US$ 70.41
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 2 available

Add to basket

Seller Image

Olena Kolesnikova
Published by LAP LAMBERT Academic Publishing, 2020
ISBN 10: 6202528729 ISBN 13: 9786202528726
New Taschenbuch
Print on Demand

Seller: AHA-BUCH GmbH, Einbeck, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In recent years, the concept of 'cardiometabolic risk' is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine the prognosis and life expectancy of patients.The monograph presents the results of our own studies that demonstrated the involvement of 'new' markers - C-reactive protein, tumor necrosis factor- , endothelial dysfunction indicators such as: circulating desquamated endothelial cells, vascular endothelial growth factor and telomere length in the formation of cardiometabolic changes in patients with NAFLD on the background of subclinical hypothyroidism, which can lead to early vascular aging. The data obtained expands our understanding of cardiometabolic risk formation mechanisms, to predict the course of the disease and to individualize the strategy for the prevention of cardiovascular events in a comorbid patient. Seller Inventory # 9786202528726

Contact seller

Buy New

US$ 34.93
Convert currency
Shipping: US$ 71.22
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 1 available

Add to basket